WELLINGTON, NZ: Volpara Health Technologies Limited, a medical technology company whose AI imaging algorithms assist the early detection of breast cancer, has completed its acquisition of Seattle-based MRS Systems, Inc. [the_ad id=”31605″]Dr Ralph Highnam, Volpara CEO, said of the acquisition’s completion: “We are delighted to welcome MRS Systems and its people into the Volpara group. And we are excited about the opportunity to work alongside MRS Systems in the United States and to grow Volpara’s service offering in the increased number of US breast clinics to which Volpara now has immediate access.
“The acquisition has involved a tremendous effort from people in both organisations, and I would like to express my thanks to everyone as we look forward to the future with a stronger US base and an extended range of integrated products which will help detect breast cancer earlier.”
MRS Systems is a medical software company that provides comprehensive patient tracking and communication, and a radiology reporting platform for sub-specialty radiology applications including breast and lung imaging.
The acquisition of MRS Systems is consistent with Volpara’s goal to save families from breast cancer through the use of AI imaging algorithms to assist the early detection of breast cancer. Application of AI requires well-curated data, and the combination of the two companies opens up that potential.
The acquisition of MRS Systems instantly increases the number of US breast clinics to which Volpara has access from 400 to over 2,000. This access will provide a platform to enable many more women to benefit from Volpara’s clinical and enterprise management software while ultimately generating the massive amounts of data that optimise AI.